MedTrace Logo

Analysis of the Gut Microbiota Composition After Consumption of Probiotic Bacteria

NCT07046897 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-02

No results posted yet for this study

Summary

The goal of this intervention study is to evaluate the beneficial effect of the probiotic bacterium Bacillus coagulans in healthy volunteers. The main question it aims to answer is if the probiotic strains are modifying the microbiota composition in a beneficial way, evaluated in faecal- and saliva samples.

Primary hypothesis: The probiotic bacteria will modify the microbiota composition in faecal- and saliva samples.

Participants will consume the freeze-dried probiotic bacteria for 14 days. Before and after consumption, the participants will collect samples.

Conditions

  • Microbiota Analysis in Healthy Subjects

Interventions

DIETARY_SUPPLEMENT

Consumption of probiotics strain 5

Consumption of probiotic capsules containing the probiotic bacteria Bacillus coagulans strain 5.

DIETARY_SUPPLEMENT

Consumption of probiotics strain 6

Consumption of probiotic capsules containing the probiotic bacteria Bacillus coagulans strain 6.

Sponsors & Collaborators

  • Lund University

    lead OTHER

Principal Investigators

  • Åsa Håkansson, Associate Professor · Lund University, LTH

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-12
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07046897 on ClinicalTrials.gov